Active Iron Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $9.6M

  • Investors
  • 8

Active Iron General Information

Description

Developer of pharmaceutical drugs and supplements intended to tackle inadequate nutrient levels around the world. The company's protein formula targets the site where the body naturally absorbs iron which increases the amount of iron absorbed, providing patients with products that help reduce gut irritation from iron and are kind to the stomach.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • Hoffmann Park, Little Island
  • Cork T45 YX04
  • Ireland
+353 (021) 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Active Iron Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 18-Dec-2020 $9.6M 000.00 000.00 Completed Generating Revenue
4. Later Stage VC 21-Jun-2018 00.000 00.00 000.00 Completed Generating Revenue
3. Early Stage VC 31-Dec-2013 00.000 00.000 0000 Completed Startup
2. Grant 13-Nov-2012 $68.1K Completed Startup
1. Spin-Off 01-Jan-2009 Completed Startup
To view Active Iron’s complete valuation and funding history, request access »

Active Iron Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
A Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Preferred Ordinary 0,000 00.000000 0000.0 0000.0 00 0000.0 0.000
G Ordinary 000 00.000000 0000.00 0000.00 00 0000.00 0.000
Preferred Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
F Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
G Ordinary 000 00.000000 0000.00 0000.00 00 0000.00 0.000
E Ordinary 2,570 $0.012030 $158.79 $158.79 1x $158.79 1.37%
F Ordinary 10,586 $0.012030 $142.06 $142.06 1x $142.06 5.63%
To view Active Iron’s complete cap table history, request access »

Active Iron Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceutical drugs and supplements intended to tackle inadequate nutrient levels around the world. The co
Pharmaceuticals
Cork, Ireland
19 As of 2023
000.00
00.00 0000-00-00
0000000000 0 000.00

000000

lla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
000000000000000
East Rutherford, NJ
0000 As of 0000
00000
000000000 00000

000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
000000000000000
Lugano, Switzerland
000 As of 0000
0000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Active Iron Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cambrex Private Equity-Backed East Rutherford, NJ 0000 00000 000000000 00000
Helsinn Healthcare Private Equity-Backed Lugano, Switzerland 000 0000000 0000
ZCL Chemicals Private Equity-Backed Mumbai, India 000 000.00 000000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Active Iron Patents

Active Iron Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2560769-B Compounds and compositions for use in treating psoriasis Active 24-Mar-2017 0000000000 0
GB-2560769-A Compounds and compositions for use in treating psoriasis Active 24-Mar-2017 0000000000 0
GB-201704759-D0 Compounds and compositions for use in treating psoriasis Active 24-Mar-2017 0000000000
US-11179380-B2 Compounds and compositions for use in treating psoriasis Active 24-Mar-2017 0000000000 0
US-20210106576-A1 Compounds and compositions for use in treating psoriasis Active 24-Mar-2017 A61K31/455
To view Active Iron’s complete patent history, request access »

Active Iron Executive Team (5)

Name Title Board Seat Contact Info
Pat O'Flynn Co-Founder & Chief Executive Officer
George Walsh Chief Financial Officer
John Gilmer Ph.D Co-Founder & Vice President of Research
Mark Ledwidge Ph.D Co-Founder
Peter Caldini Chairman
To view Active Iron’s complete executive team members history, request access »

Active Iron Board Members (3)

Name Representing Role Since
Michael Buckley Self Vice Chairman 000 0000
Peter Caldini Self Chairman 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Active Iron Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Active Iron Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
RAB Capital Asset Manager Minority 000 0000 000000 0
Anne Heraty Angel (individual) Minority 000 0000 000000 0
David Power Angel (individual) Minority 000 0000 000000 0
Ergo Corporation Minority 000 0000 000000 0
Healy Chemicals Corporation Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »